New/Old: PRONECMO and EOLIA
ICU Ed and Todd-Cast
Clinical Trial on ECMO vs Conventional Treatment for Severe ARDS
The chapter delves into an international randomized control trial comparing ECMO to conventional treatment for severe ARDS, focusing on patient selection criteria and primary 60-day mortality outcomes. It explores the challenges faced during the trial, the relative risk of mortality in the ECMO group compared to the control group, and the early trial cessation due to futility concerns.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
